About Us

Veyond Metaverse strives to disrupt the healthcare industry by offering innovative, haptic-enhanced extended reality (XR) technology.

Our Mission

Bridging the Healthcare Training Gap with XR+AI Solutions

Company History

Born from the renowned MIMS Lab at Toronto Metropolitan University, Veyond Metaverse is leading the charge in revolutionizing medical education and collaboration.


With seed funding and partnerships with industry leaders, Veyond Connect was launched, offering real-time communication with unparalleled immersion.

Already validated at prestigious hospitals, Veyond Connect is poised to transform the healthcare industry.

Leadership Team

Advisors

Roadmap and Milestones

NOV, 2022

  • VeyondConnect Alpha completed
  • Pretium lectus quam id leo. Urna et pharetra pharetra massa massa. Adipiscing enim eu neque aliquam vestibulum morbi blandit cursus risus.

NOV, 2022

  • ProvisionalIP for advanced immersive communication system filed
  • Pretium lectus quam id leo. Urna et pharetra pharetra massa massa. Adipiscing enim eu neque aliquam vestibulum morbi blandit cursus risus.

NOV, 2022

  • Productlaunch of VR based immersive training applications
  • Pretium lectus quam id leo. Urna et pharetra pharetra massa massa. Adipiscing enim eu neque aliquam vestibulum morbi blandit cursus risus.

NOV, 2022

  • VeyondConnect Beta completed
  • Pretium lectus quam id leo. Urna et pharetra pharetra massa massa. Adipiscing enim eu neque aliquam vestibulum morbi blandit cursus risus.

NOV, 2022

  • FDA510(k) submission for Veyond Connect preoperative imaging analysis
  • Pretium lectus quam id leo. Urna et pharetra pharetra massa massa. Adipiscing enim eu neque aliquam vestibulum morbi blandit cursus risus.

NOV, 2022

  • Veyond Connect deployment in Asia
  • Pretium lectus quam id leo. Urna et pharetra pharetra massa massa. Adipiscing enim eu neque aliquam vestibulum morbi blandit cursus risus.

NOV, 2022

  • VeyondConnect deployment in Latin America
  • Pretium lectus quam id leo. Urna et pharetra pharetra massa massa. Adipiscing enim eu neque aliquam vestibulum morbi blandit cursus risus.

NOV, 2022

  • Filingof two critical patents involving a 3D real-time volumetric videostreaming
  • Pretium lectus quam id leo. Urna et pharetra pharetra massa massa. Adipiscing enim eu neque aliquam vestibulum morbi blandit cursus risus.

NOV, 2022

  • Filingseveral FDA 510(k) submissions -robotic apparatus training, assistance,real-time surgical applications
  • Pretium lectus quam id leo. Urna et pharetra pharetra massa massa. Adipiscing enim eu neque aliquam vestibulum morbi blandit cursus risus.

NOV, 2022

  • Growingnumber of paying users for Veyond Connect